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OBJECTIVE: To identify the impact of supplemental zinc, vitamin A, and glutamine, alone or in combination, on
long-term cognitive outcomes among Brazilian shantytown children with low median height-for-age z-scores.
METHODS: A randomized, double-blind, placebo-controlled trial was conducted in children aged three months
to nine years old from the urban shanty compound community of Fortaleza, Brazil. Demographic and
anthropometric information was assessed. The random treatment groups available for cognitive testing (total
of 167 children) were: (1) placebo, n=25; (2) glutamine, n= 23; (3) zinc, n = 18; (4) vitamin A, n=19; (5)
glutamine+zinc, n= 20; (6) glutamine+vitamin A, n=21; (7) zinc+vitamin A, n=23; and (8) glutamine+zinc+vi-
tamin A, n=18. Neuropsychological tests were administered for the cognitive domains of non-verbal
intelligence and abstraction, psychomotor speed, verbal memory and recall ability, and semantic and phonetic
verbal fluency. Statistical analyses were performed using SPSS, version 16.0. ClinicalTrials.gov: NCT00133406.
RESULTS: Girls receiving a combination of glutamine, zinc, and vitamin A had higher mean age-adjusted verbal
learning scores than girls receiving only placebo (9.5 versus 6.4, p=0.007) and girls receiving zinc+vitamin A (9.5
versus 6.5, p=0.006). Similar group differences were not found between male study children.
CONCLUSIONS: The findings suggest that combination therapy offers a sex-specific advantage on tests of verbal
learning, similar to that seen among female patients following traumatic brain injury.
KEYWORDS: Malnutrition; Cognition; Zinc; Vitamin A; Glutamine; Child.
Lima AA, Kvalsund MP, Souza PP, Figueiredo IL, Soares AM, Mota RM, et al. Zinc, vitamin A, and glutamine supplementation in Brazilian
shantytown children at risk for diarrhea results in sex-specific improvements in verbal learning. Clinics. 2013;68(3):351-358.
Received for publication on September 12, 2012; First review completed on September 28, 2012; Accepted for publication on November
19, 2012
E-mail: rbo5u@virginia.edu
Tel.: 55 85 3366-8239
& INTRODUCTION
The vicious cycle of diarrhea/malnutrition in early
childhood acts synergistically to impair the child’s full
developmental potential. A series of cohort studies from our
group, enrolling children under diarrhea and enteric disease
surveillance in the first two years of life, has documented
significant growth shortfalls (1), blighted cognitive potential
(2), and subsequent poor school performance during the
developmental childhood years (3). While these long-term
negative outcomes have been well documented, our under-
standing of measures that could prevent or reverse these
cognitive short falls is very limited. Micronutrients, such as
zinc, vitamin A, and glutamine, hold promise to avert these
deficits due to these compounds’ potential role in protecting
the brain and in intestinal development (4,5).
Numerous clinical zinc supplementation trials have
revealed decreased diarrheal mortality and morbidity in
children following supplementation (6). In addition, a
pooled analysis of 37 supplementation trials regarding the
impact of zinc supplementation on growth shortfalls
revealed a highly significant impact on linear growth in
prepubertal children (7). The mechanisms by which zinc
acts to protect against diarrhea and growth deficits are not
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fully understood, but they are likely multi-factorial, includ-
ing anti-bactericidal and antioxidant effects (8,9), with
improved mucosal immune response and recovery (10).
Zinc is also involved in neurogenesis, neuronal migration,
and synaptogenesis (11,12), and oral zinc supplementation
improved behavioral and hippocampal development in a
murine model of under-nutrition early in life (13).
Vitamin A deficiency is a well-recognized cause of
preventable blindness, but it now is also being recognized
for its maintenance of intestinal epithelial integrity and the
immune response (14). These effects could explain the
reductions of the mortality and severity of diarrheal
episodes seen following vitamin A supplementation in
children.
Further, while the importance of vitamin A in embry-
ogenesis and congenital abnormalities has been well
documented, very little is known about the importance of
post-natal vitamin A deficiency in the healthy functioning of
the central nervous system. Studies of retinoid knockout
mice and mice subjected to post-natal vitamin A deprivation
have suggested that retinoid signaling pathways play
critical roles in higher cognitive functioning in the central
nervous system (15). No studies have been conducted
regarding the impact of vitamin A supplementation alone
on cognitive outcomes in humans.
Glutamine is a major energy source for the intestinal
mucosa, and it plays a key role in nucleic acid biosynthesis
(16). Glutamine supplementation has been associated with
improved gastrointestinal function in a variety of clinical
scenarios, including ameliorating mucosal atrophy after
parenteral nutrition (17), improving gut mucosal healing
following cancer therapy (18), and enhancing enteric
immune responses (16). Glutamine is also found abundantly
in the central nervous system, where it acts as a precursor of
neurotransmitter amino acids, an oxidative energy source,
and an ammonia detoxifier (19). To the best of our
knowledge the impact of glutamine supplementation on
cognition has never been investigated in children.
This prospective, randomized, double-blind, placebo-
controlled trial investigated the impact of supplemental
zinc, vitamin A, and glutamine, alone or in combination, on
long-term cognitive outcomes in a group of high-risk
children identified as below the median height-for-age z-
score (HAZ) in a slum community in Fortaleza-Ceara´,
Brazil.
& METHODS
Population
This study was undertaken in the urban shanty com-
pound community of Parque Universita´rio, Fortaleza, the
capital of the state of Ceara´ in northeast Brazil. All children
(identified through a community census) between three
months and nine years of age and below the median height-
for-age z-score (HAZ, population median = -0.06) were
eligible to participate. The latter eligibility criterion was
selected because of the high predictive value of HAZ scores
in identifying children with chronic, persistent diarrheal
episodes in the first two years of life (20). The exclusion
criteria included children being exclusively breast-fed,
participants in any study over the previous two years, and
children having illnesses with fevers greater than 38 C˚ at the
time of enrollment.
Study Design and Baseline Evaluation
This study was a prospective, double-blind, randomized,
placebo-controlled trial and was registered as a clinical trial
(NCT00133406) with the US National Library of Medi-
cine (http://www.clinicaltrials.gov). Enrollment/recruit-
ment was conducted from June 2000 to August 2004. After
parental consent was obtained, the parents and children
were interviewed by an experienced field study team (one
nurse and two community health workers) to collect
demographic information, including age, sex, birth weight,
level of maternal education, family income, and baseline
anthropometric information. Weight was measured using a
calibrated digital weighing scale with 100 g precision
(Tanita Solar Scale, Tanita Corporation of American Inc.,
Arlington, IL, USA). Height was measured in the supine
position for children younger than 24 months of age and
standing for children aged 24 months old or older using an
anthropometric rod with an accuracy of 0.1 cm. HAZ,
weight-for-age z-scores (WAZ), and weight-for-height z-
scores (WHZ) were calculated using the Epi-Info anthropo-
metric software (Center for Disease Control, Atlanta, GA,
USA) as markers of physical development and nutritional
status. These anthropometric z-scores are the numbers of
standard deviations greater or less than the median values
for the National Center for Health Statistics (NCHS) and
International Reference Population (21).
Sample Size Calculation
A sample size was calculated to allow for appropriate
power to detect group differences in cognitive scores
between children receiving zinc plus vitamin A compared
with children receiving no vitamin A or zinc, averaging the
difference in children receiving glutamine and children not
receiving glutamine. Using a two-tailed test with type I
error = 5%, 35 children per cell were calculated to be
sufficient to have 80% power to detect a difference of 0.36
(small to medium effect size) and 90% power to detect a
difference of 0.42 (medium effect size).
Nutritional Intervention and Surveillance
Three hundred and fourteen children were randomized
with regard to receiving vitamin A (100,000 IU retinyl
palmitate if ,12 months old or 200,000 IU retinyl palmitate
if $12 months old every four months), one dose at 0, four,
and eight months of the study protocol; zinc (40 mg twice
weekly); or both for one year. Half of each group received
glutamine (16 g daily given over ten days started during the
first month of the study protocol) (22), of whom one
hundred and sixty-seven were available and eligible for
cognitive testing. Only trained health care agents of the
study surveillance team administered all of the micronu-
trients. The health workers administered the micronutrients
during home visits with direct observation of intake. L-
glutamine was obtained from Rexim (Courbevoie, France);
L-glycine was obtained from Spectrum Chemicals (Gardena,
CA, USA); zinc acetate was obtained from Spectrum
Chemicals; and vitamin A (retinyl palmitate in vegetable
oil with 40 IU of alpha-tochopherol as an antioxidant) was
obtained from Hoffman-La Roche (Basel, Switzerland).
Isomolar glycine (8.3 g/daily) was used as a placebo for
glutamine. Tanjal juice was used as the placebo for zinc, and
the same amounts of alpha-tocopherol and vegetable oil
were used as the placebo for vitamin A. Tocopherol was
chosen as the placebo for vitamin A because it is also a
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fat-soluble vitamin, and the tocopherol-dosing preparation
is similar to vitamin A capsule dosing. The vitamin A and
placebo capsules were the same color, size, and taste.
A computer-generated random number list assigned the
children to one of eight treatment arms, including: 1)
placebo; 2) glutamine; 3) zinc; 4) vitamin A; 5) glutamine+-
zinc; 6) glutamine+vitamin A; 7) zinc+vitamin A; or 8)
glutamine+zinc+vitamin A. The treatment groups and oral
treatment regimens, including dose, frequency, and dura-
tion of supplementation, are outlined in Table 1. A member
of the field study team blinded to treatment group
administered the supplementations and visited each child
twice weekly to assess tolerance and any adverse effects of
supplementation. No significant differences in the rates of
adverse events were found among the treatment groups.
Neuropsychological Assessment
Children who completed the supplementation protocol
and were at least five years of age (appropriate age for
testing) underwent five cognitive tests at an average of four
years later (range 1.4-6.6). The following tests with Brazilian
adaptations were included: the Test of Non-Verbal
Intelligence, 3rd Edition (TONI-3); the Wide Range
Assessment of Memory and Learning, 2nd Edition
(WRAML-2); Verbal Learning and Delayed Recall; the
Weschler Intelligence Scale for Children (WISC) Coding A
(for children ages 5-7) and Coding B (for children ages 8-13);
and the Developmental Neuropsychological Assessment
(NEPSY) Verbal Fluency test. The cognitive assessment
chosen covered the cognitive domains of non-verbal
intelligence and abstraction, psychomotor speed, verbal
memory and recall ability, and semantic and phonetic
verbal fluency. These tests have been used in previous
studies in this population (2) and in other non-English-
speaking populations (23). All of the tests were adminis-
tered in a standardized manner and scored by a Brazilian
developmental psychologist who was blinded to treatment
group. The tests were administered in a silent room located
in a school facility within the community.
Ethical Approval
The study protocol and informed consent form were
approved by the Comiteˆ de E´tica em Pesquisa e Complexo
Hospitalar (COMEPE) at the Federal University of Ceara´
(UFC), Fortaleza, Ceara´, Brazil; Conselho Nacional de E´tica
em Pesquisa (CONEP) at the Ministry of Health, Brası´lia,
Brazil; and the University of Virginia IRB for Health
Services Research. In addition, the study was followed
and approved by the Data Safety and Management Board
(DSMB) at the National Institutes of Health.
Statistical Analysis
The data were double-entered by independent persons and
validated using Excel software, version 4.0. All of the data
were analyzed using the SPSS statistical software package
(SPSS, Inc. Chicago, IL, USA). A one-way analysis of variance
with post-hoc least significant difference (LSD) tests for two-
by-two group comparisons was used to identify simple main
effect differences in age at study entry, age at cognitive
testing, time between cognitive testing and study enrollment,
sex, birth weight, maternal education, family income, and
nutritional parameters at study entry and conclusion,
including weight-for-age WAZ, HAZ, and WHZ z-scores,
as well as performance on the neuropsychological assess-
ments. The treatment groups were further categorized into
four micronutrient exposure groups, including zinc, vitamin
A, zinc+vitamin A, or glutamine, and compared with regard
to these variables to identify the impact of simple single or
combination micronutrient exposures on study variables. An
analysis of covariance was used to adjust for the influence on
cognitive performance in terms of sex and the time between
study enrollment and cognitive assessment. Continuous
variables in tables are presented as the means¡standard
deviations. Categorical variables are presented as percen-
tages of the total population. A p-value,0.05 was considered
statistically significant.
& RESULTS
A flow chart of the study children is provided in Figure 1.
A total of 324 children were identified and screened for
study eligibility, of whom 201 (64%) completed nutrient
supplementation during the 12-month study protocol.
Among children completing the supplementation protocol,
167 (83%) children underwent the cognitive examinations.
The most common reason for not undergoing the cognitive
testing was that the child was younger than five years of age
and thus too young to undergo the tests (n = 30). Children
Table 1 - Treatment groups and oral treatment regimens of the study participants. A randomized, double-blind, and
placebo-controlled clinical trial of zinc, vitamin A, and glutamine supplementation in Brazilian shanty-town children
from Fortaleza, CE, northeastern Brazil, during June 2000 and August 2004, with follow-up between June 2000 and
December 2007.
Treatment Group Oral Treatment Regimen
Placebo Placebo* (Placebo glutamine+Placebo zinc+Placebo vitamin A)
Glutamine Glutamine**+Placebo zinc+Placebo vitamin A
Zinc Zinc{+Placebo glutamine+Placebo vitamin A
Vitamin A Vitamin A{+Placebo zinc+Placebo glutamine
Glutamine+Zinc Glutamine**+Zinc{+Placebo vitamin A
Glutamine+Vitamin A Glutamine**+Vitamin A{+Placebo zinc
Zinc+Vitamin A Zinc{+Vitamin A{+Placebo glutamine
Glutamine+Zinc+Vitamin A Glutamine**+Zinc{+Vitamin A{
*Isomolar glycine doses (8.3 g/day) over ten days started at one month of the study protocol; zinc vehicle (Tanjal juice) twice weekly for twelve months;
placebo retinol = vitamin E (tocopherol 40 IU) each for four months at 0, four, and eight months.
**Oral glutamine (16.2 g/day) for ten days starting at one month of the study protocol. { Zinc (zinc acetate) 40 mg twice weekly for 12 months.
{Vitamin A (retinyl palmitate) 100,000 IU for children,12 months or 200,000 IU for children at least 12 months old, given as one dose at 0, four, and eight
months of the study protocol.
CLINICS 2013;68(3):351-358 Combination Micronutrients and Cognition
Lima AA et al.
353
who completed the cognitive testing did not differ sig-
nificantly from children who did not undergo cognitive
testing with regard to sex, birth weight or length, or baseline
WAZ or WHZ. However, the children who completed
cognitive testing were significantly older (p,0.001),
weighed more and were taller at baseline (both p-values
,0.001), and had better baseline HAZ scores (p= 0.026) than
those who did not complete the cognitive testing.
Table 2 outlines the demographic and other character-
istics of the children who completed cognitive testing,
overall and by treatment group. The study children ranged
from five to 13 years of age at the time of cognitive testing.
Slightly more than half of the study children were female
(53%). Only 30 children (18%) had mothers with more than a
primary school education. Data on family income were
available for 123 children, of whom 59 (48%) were living in a
household earning the Brazilian minimum wage of 415
Brazilian Reais per month (equivalent to 265 USD per
month) or less. No significant group differences were
identified regarding age at study entry, age at cognitive
testing, time between cognitive testing and study entry, sex,
birth weight, maternal education, or family income.
Regarding nutritional parameters, no significant group
differences were identified at study entry or conclusion
regarding HAZ, WAZ, or WHZ scores, with the exception
that children in the combination glutamine, zinc, and
vitamin A group had higher WAZ scores at study entry
compared with placebo children (p= 0.04). This placebo
versus combination glutamine, zinc, and vitamin A group
difference in WAZ scores almost reached significance at the
end of the study (p= 0.06).
Cognitive Performance
The mean age-adjusted cognitive test scores for all eight
treatment arms are presented in Table 3. No significant
group differences were found regarding the age-adjusted
TONI-3 Intelligence Quotient (IQ), WISC-III Coding,
WRAML-2 Delayed Verbal Learning, or NEPSY Verbal
Fluency mean scores. z-scores for semantic and phonetic
fluency among children aged 6-12 years old were also
compared across treatment groups to identify any differ-
ential impact of supplementation group on verbal fluency
categories. No significant group differences were identified
based on verbal fluency subtest z-scores. However, children
receiving combination glutamine, zinc, and vitamin A
performed significantly better on WRAML-2 verbal learning
than the placebo group, with mean age-adjusted scores of
9.28 (SD 3.41) and 7.28 (SD 3.34), respectively (p= 0.02).
After controlling for time between study entry and cognitive
assessment, sex stratification revealed that this improve-
ment in verbal learning was highly significant among the
girls (p= 0.007) but not among the boys (p= 0.43) who
received combination glutamine, zinc, and vitamin A versus
placebo (Table 4). In addition, female children receiving
combination glutamine, zinc, and vitamin A performed
significantly better on verbal learning than female children
Figure 1 - Flow of Study Children to Micronutrient Supplementation Groups and Cognitive Testing.
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receiving zinc and vitamin A alone (p= 0.006). These group
differences persisted after controlling for differences in
baseline WAZ scores. However, within the placebo group,
the girls had worse verbal learning scores than the boys
(p,0.05).
No significant between group differences were identified
before or after sex stratification on the WRAML-2 delayed
verbal learning score. This combination group effect also
almost reached statistical significance compared with
female children receiving glutamine and zinc alone
(p= 0.08).
The treatment arms were also categorized into four
groups based on micronutrient exposure (i.e., zinc, vitamin
A, combination zinc+vitamin A, or glutamine) to assess the
differential impact of exposure to a specific single micro-
nutrient or combination of micronutrients on cognitive test
performance. The results of cognitive testing revealed no
significant between group differences based on micronu-
trient exposure categories.
& DISCUSSION
This study found a superior impact of combination
glutamine, zinc, and vitamin A supplementation on the
WRAML-2 verbal learning in a group of children with low
to median HAZ scores (and thus at high risk for the
cognitive deficits seen in children with childhood diarrhea
and malnutrition). These findings were statistically signifi-
cant overall, but sex stratification identified highly signifi-
cant differences only between female children receiving
combination therapy and girls receiving zinc and vitamin A
alone or placebo. Supplementation was found to be
beneficial in girls compared with the placebo group. Thus,
the combined intervention with glutamine, zinc, and
vitamin A was more important to the female group because
the girls were more affected than the boys.
No other differences were identified between supplemen-
tation treatment groups or following the categorization of
treatment groups into one of four exposure groups.
Table 2 - Demographics and other characteristics of the study participants. A randomized, double-blind, and placebo-
controlled clinical trial of zinc, vitamin A, and glutamine supplementation in Brazilian shanty-town children from
Fortaleza, CE, northeastern Brazil, during June 2000-August 2004, with follow-up between June 2000 and December
2007.
Placebo
(n=25)
Glutamine
(n= 23)
Zinc
(n= 18)
Vitamin
A (n=19)
Glutamine+
Zinc (n=20)
Glutamine+
Vitamin A (n=21)
Zinc+Vitamin
A (n=23)
Glutamine+Zinc+
Vitamin A (n=18)
Total
(n = 167)
Age at Study Entry (months) 48.8¡29.8 53.9¡28.2 62.2¡26.0 43.3¡25.5 55.2¡28.3 54.8¡29.0 59.5¡26.1 56.0¡25.5 54.1¡27.4
Age at Cognitive Testing
(years)
8.43¡2.02 8.73¡2.18 9.20¡2.20 7.55¡2.14 8.76¡1.87 8.61¡1.99 8.98¡2.30 8.34¡1.86 8.58¡2.08
Time between Cognitive
Testing and Study Entry
(years)
4.42¡1.46 4.29¡1.31 4.09¡1.15 3.99¡1.48 4.22¡1.34 4.10¡1.32 4.09¡1.15 3.73¡1.33 4.13¡1.33
Female n (%) 12 (48) 9 (39) 11(61) 9 (47.4) 9 (45) 9 (43) 16 (70) 13 (72) 88 (53)
Birth weight 2.93¡0.63 3.18¡0.45 3.13¡0.68 3.10¡0.52 3.19¡0.41 3.13¡0.54 3.22¡0.37 3.2¡0.42 3.13¡0.51
Maternal Education (,
primary school) n (%)
5 (20) 2 (9) 6 (33) 3 (16) 2 (11) 6 (29) 3 (14) 3 (18) 30 (18)
Family Income.than
Minimum Wage n (%)
9 (53) 11 (65) 6 (60) 4 (31) 9 (60) 11(61) 8 (50) 6 (35) 67 (55)
Nutritional Parameters at Study Baseline
Weight-for-Age z score -1.00¡1.10 -0.42¡0.84 -0.55¡0.82 -0.47¡1.04 -0.54¡0.92 -0.85¡0.81 -0.99¡0.98 -0.41¡0.80* -0.67¡0.94
Height-for-Age z score -1.26¡0.97 -0.69¡0.89 -0.80¡1.01 -0.86¡0.79 -0.95¡0.90 -1.01¡0.91 -1.07¡0.95 -0.82¡0.69 -0.95¡0.90
Weight-for-Height z score -0.25¡1.13 0.10¡0.87 -0.07¡0.82 0.15¡1.01 0.12¡0.93 -0.33¡1.00 -0.42¡0.93 0.25¡1.12 -0.07+0.99
*Combination Zinc+Vitamin A+Glutamine versus Placebo, p=0.04.
Table 3 - Mean age-adjusted (scaled) performance on cognitive tests by treatment group. A randomized, double-blind,
placebo-controlled clinical trial of zinc, vitamin A, and glutamine supplementation in Brazilian shanty-town children
from Fortaleza, CE, northeastern Brazil, during June 2000-August 2004, with follow-up between June 2000 and
December 2007.
Cognitive Tests
Placebo
(n=25)
Glutamine
(n= 23) Zinc (n = 18)
Vitamin A
(n=19)
Glutamine+
Zinc (n =20)
Glutamine+
Vitamin A (n =21)
Zinc+Vitamin
A (n=23)
Glutamine+Zinc+
Vitamin A (n=18)
IQ 79.1¡9.12 81.8¡7.76 79.9¡6.92 82.2¡5.87 80.4¡8.05 81.91¡7.12 82.5¡9.94 82.1¡9.78
Coding 9.45¡3.51 10.4¡3.13 9.67¡3.66 9.84¡3.15 9.75¡3.17 9.71¡3.78 9.78¡4.17 10.8¡3.38
Verbal Learning 7.28¡3.34 8.43¡2.41 7.61¡2.40 8.74¡2.47 8.15¡2.83 7.9¡2.77 7.57¡2.81 9.28¡3.41**
Delayed Verbal
Learning
8.20¡2.69 7.78¡1.57 8.00¡1.88 7.79¡2.22 8.35¡2.08 8.71¡2.43 8.52¡2.64 8.11¡3.08
Verbal Fluency 6.22¡2.70 6.67¡2.67 7.11¡3.59 5.74¡2.35 5.95¡2.81 6.75¡2.65 6.36¡2.95 7.33¡2.63
NEPSY Verbal Fluency Subtest Z-scores*
Semantic Fluency -1.17¡0.84 -0.63¡0.78 -0.43¡0.82 -1.15¡0.49 -0.63¡0.86 -0.36¡0.94 -0.82¡0.73 -1.24¡1.38
Phonetic Fluency -1.38¡0.67 -1.48¡0.71 -1.04¡1.19 -1.56¡0.80 -1.49¡0.70 -1.18¡0.88 -1.54¡0.87 -1.14¡0.83
*Children aged 6-12 years old only; **Comparison of Combination Glutamine+Zinc+Vitamin A versus placebo, p=0.02.
IQ= intelligence quotient.
NEPSY=A developmental neuropsychological assessment.
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Previous studies from our group have shown improvements
in intestinal barrier function after a ten day treatment
regimen of glutamine-enriched formula (22). A recent meta-
analysis showed that zinc supplementation reduces diar-
rhea morbidity in children, especially after six months of
age (24); both of these effects could be helpful during the
critical time window for brain development in the study
children, who live in endemic areas of enteric infections and
malnutrition.
This sex-specific benefit of combination glutamine, zinc,
and vitamin A supplementation was an unexpected finding.
Studies of recovery following traumatic brain injury (TBI) in
children have shown a female recovery advantage in verbal
list learning (25,26). In a study of 60 children (aged 6-16
years) with TBI identified through a private rehabilitation
center in the midwestern U.S., female children performed
significantly better than male children on the California
Verbal Learning Test-Children’s Version, even after con-
trolling for the impact of the severity of head injury (25). In
contrast with these findings, there have been studies
reporting a sex-specific decrease in intelligence test results
in children treated for acute lymphoblastic leukemia, with
girls showing lower IQ scores than boys (27,28), in contrast
with the specific deficits in verbal learning seen in our study
and the verbal intelligence deficits seen in pediatric
intracranial hemorrhage and TBI studies.
Our study, which included children at high risk for the long-
term cognitive deficits seen with childhood diarrhea and
malnutrition (based on low baseline HAZ scores), supports the
findings of verbal list learning advantages following combina-
tion glutamine, zinc, and vitamin A supplementation.
There is accumulating evidence that b-estradiol (the
primary biological form of estrogen) not only has a
neuroprotective role but might also activate restorative
processes, improving learning and memory, and promote
the formation of synapses in the nervous system during
aging and early development, as seen in animal models
(29,30). However, estradiol-based hormonal treatment in
post-menopausal women has been found to be detrimental,
increasing the risk of dementia and stroke (30).
Furthermore, sex differences during cognitive development
remain controversial (31). One potential explanation for
these contradictory findings is the requirement that b-
estradiol interact with IGF-1 for its neuroprotective effects
(32). This study did not evaluate IGF-1 serum levels in these
children (a study that is under way by our group); however,
early weight gain and subsequent linear growth were
associated with increments in serum IGF-1 levels. The
neuroprotective effects of the combination nutritional
therapy seen in the girls in this study might be related to
improved IGF-1 interactions. More studies are warranted to
test this hypothesis.
Zinc supplementation trials in human children have not
consistently shown improvement in cognitive outcomes. A
randomized, controlled zinc supplementation trial in 740
Chinese children aged six to nine years attending three peri-
urban schools found that children receiving micronutrient
supplementation plus 20 mg of zinc six days/week for ten
weeks had significantly improved fine and gross motor
skills, attention, abstract concept formation, and abstract
reasoning skills compared with children who received
micronutrient supplementation without zinc or who
received zinc supplementation alone (23). However, a study
of 162 Guatemalan school children aged seven to eight years
receiving 20 mg zinc/day for 25 weeks failed to find any
significant differences after six months of follow-up in
mental concentration or short-term memory compared with
children receiving a placebo (24). Similarly, no significant
differences in attention were found among 60 Canadian
boys with low height percentiles attending first grade (aged
5-7 years) in 47 schools in southern Ontario who received
10 mg of zinc in a 1 mL solution of ZnSO4 added to apple/
orange juice compared with children receiving a similar
placebo solution (25). These differences might be related to
the prevalence and severity of zinc deficiencies in the study
population, the impact of other concurrent micronutrient
deficiencies, the simultaneous use of other supplements, the
dose and duration of the supplementation, and the
sensitivity and appropriateness of the neuropsychological
testing employed.
Table 4 - Mean and standard deviations of age-adjusted performance on cognitive tests by sex after adjusting for time
between study enrollment and cognitive evaluation. A randomized, double-blind, placebo-controlled clinical trial of
zinc, vitamin A, and glutamine supplementation in Brazilian shanty-town children from Fortaleza, CE, northeastern
Brazil, during June 2000-August 2004, with follow-up between June 2000 and December 2007.
Cognitive
Tests Placebo Glutamine Vitamin A Zinc
Glutamine+
Zinc
Glutamine+
Vitamin A
Zinc +
Vitamin A
Glutamine+
Zinc+Vitamin A
Female
IQ 82.6 (2.4) 83.2 (2.8) 81.1 (2.8) 80.0 (2.5) 83.7 (2.8) 83.3 (2.8) 81.7 (2.1) 81.1 (2.1)
Coding 10.1 (1.1) 11.0 (1.2) 11.2 (1.2) 10.7 (1.1) 10.1 (1.2) 10.4 (1.2) 9.7 (0.9) 11.4 (1.0)
Verbal Learning 6.4 (0.8)* 7.6 (0.9) 8.3 (0.9) 8.3 (0.8) 7.3 (0.9) 7.5 (0.9) 6.5 (0.7)** 9.5 (0.8)
Delayed Verbal Learning 5.0 (8.5) 7.5 (11.1) 6.7 (8.8) 6.6 (10.8) 7.1 (10.9) 7.8 (11.6) 6.7 (10.7) 6.2 (8.7)
Verbal Fluency 6.2 (0.9) 6.0 (1.0) 6.0 (1.0) 7.4 (0.9) 6.3 (1.0) 7.1 (1.0) 6.2 (0.7) 7.5 (0.8)
Male
IQ 75.9 (2.3) 80.9 (2.2) 82.1 (2.6) 79.7 (3.1) 77.7 (2.5) 80.7 (2.4) 84.4 (3.2) 84.8 (3.7)
Coding 8.8 (1.0) 10.0 (0.9) 8.6 (1.1) 8.0 (1.3) 9.4 (1.1) 9.2 (1.0) 10.0 (1.4) 9.6 (1.6)
Verbal Learning 8.0 (0.8) 8.9 (0.7) 9.2 (0.9) 6.6 (1.1) 8.8 (0.8) 8.2 (0.8) 9.9 (1.1) 9.0 (1.2)
Delayed Verbal Learning 6.7 (0.9) 9.3 (0.9) 7.8 (0.5) 8.7 (1.1) 9.0 (0.9) 9.7 (1.0) 8.7 (1.0) 7.4 (0.6)
Verbal Fluency 6.1 (0.8) 7.1 (0.8) 5.5 (0.9) 6.5 (1.2) 5.7 (0.9) 6.5 (0.9) 6.7 (1.1) 7.0 (1.3)
*Glutamine+Zinc+Vitamin A versus Placebo, p=0.007.
**Glutamine+Zinc+Vitamin A versus Zinc+Vitamin A, p=0.006.
IQ= intelligence quotient.
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The finding of a verbal learning benefit among female
children receiving combination glutamine, zinc, and vita-
min A supplementation addresses previous concerns that
multiple micronutrient deficiencies present in undernour-
ished children could reduce or obscure the clinical benefits
of supplementation with single micronutrients (33).
However, it should be noted that the present study did
not conduct serial micronutrient serum assessments, and
thus, the reasons for the positive effect of the full
combination of supplements compared with single supple-
ments or other combinations of supplementation remain
speculative.
Simultaneous supplementation with multiple micronutri-
ents could act synergistically to improve long-term growth
and cognitive outcomes in high-risk children by acting on
multiple organ systems, including the gastrointestinal tract,
systemic immune system, central nervous system, and
neuroendocrine axes. Previous clinical studies of multiple
micronutrient supplementation have produced divergent
results, with some reporting positive benefits on attention,
learning, and IQ, and others reporting no effects (34).
Comparisons of these trials are difficult due to variations in
population sampling, supplementation regimens (including
some macronutrient and energy supplementation), routes of
administration, durations of supplementation, and neurop-
sychological assessment instruments. No previous studies
have applied supplementation with a combination of
glutamine, zinc, and vitamin A.
It is noteworthy that the WAZ at the start of the study was
higher in the zinc+vitamin A+glutamine groups compared
with the placebo groups, which might have explained the
improved verbal learning scores in that group; however,
WAZ at start of the study was not a significant predictor of
verbal learning scores and therefore cannot be used to
explain that improvement.
Regarding limitations, we acknowledge that due to the
small size of each interventional group at the end of follow-
up, this study lost power and could have incorporated
unexpected bias in the statistical analyses; therefore, our
findings should be interpreted with caution and should be
confirmed with larger study designs.
In conclusion, we documented sex-specific improvements
in selected cognitive tests after combined nutrient supple-
mentation in at-risk children living in impoverished settings
in northeastern Brazil. More studies (now being planned by
our group) are warranted to evaluate the potential mechan-
isms of nutrient-to-nutrient interactions underlying these
findings and the potential associations with IGF-1 levels in
children.
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